Shiraz Halloush

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 4

Top Topics

Idiopathic Pulmonary Fibrosis

Helicobacter Pylori

Prognostic Factors

Top Venues

The Annals of pharmacotherapy

Pharmacy practice

Hospital pharmacy

Current medical research and opinion

This page only lists publications with an associated author ORCID identifier.

Publications

Shiraz Halloush, Nimer S Alkhatib, Abdulaali R Almutairi, Mathias Calamia, Hala Halawah, Mavis Obeng-Kusi, Martin Hoyle, Omar Rashdan, Jim Koeller, Ivo Abraham
Economic Evaluation of Three BRAF + MEK Inhibitors for the Treatment of Advanced Unresectable Melanoma With BRAF Mutation From a US Payer Perspective. The Annals of pharmacotherapy (2023)
Beisan A Mohammad, Shiraz Halloush, Luai Z Hasoun, Dalal Alnatour, Abdullah Al-Dulaimi, Munther S Alnajjar, Anaheed Blaibleh, Amniyah Al-Imam, Farhan Alshammari, Heba A Khader
Perspectives of the community in the developing countries toward telemedicine and pharmaceutical care during the COVID-19 pandemic. Pharmacy practice 20 (1) (2022)
Shiraz Halloush, Abdullah A Alhifany, Nimer S Alkhatib, Abdel Qader Al Bawab, Batool Al-Qawasmeh, Esra'a Al Shawakri, Jim Koeller
Cost-effectiveness of palonosetron and dexamethasone-based triple and quadruple regimens in preventing highly emetogenic chemotherapy-induced nausea and vomiting. Current medical research and opinion 38 (4) (2022)
Shiraz Halloush, Ivan A Reveles, Jim M Koeller
Evaluating Six Commercially Available Closed-System Drug-Transfer Devices Against NIOSH's 2015 Draft Vapor Protocol. Hospital pharmacy 55 (6) (2019)